Efficacy of Acupuncture on Chemotherapy-Induced Peripheral Neuropathy

  • STATUS
    Recruiting
  • End date
    Jun 30, 2022
  • participants needed
    94
  • sponsor
    Taipei Veterans General Hospital, Taiwan
Updated on 3 May 2021

Summary

The purpose of this study is to assess the neurological efficacy of acupuncture in patients with cancer who experienced peripheral neuropathy, which is induced by chemotherapy.

Description

Background: Chemotherapy may lead to peripheral neuropathy up to 40% in cancer survivors, especially in some types of patients with cancer. The effect of acupuncture, an ancient Chinese medicine technique, was recognized by the World Health Organization (WHO) in the treatment of several diseases. The postulated mechanisms associated with acupuncture in analgesia or neurogenesis are still under investigation. Considering a moderate recommendation for duloxetine in the treatment of chemotherapy-induced peripheral neuropathy (CIPN) based on based on neuropathic pain, and a few treatment options with evidence for CIPN, acupuncture might be another option. Nowadays, only small scale pilot studies provided initial proof of acupuncture in CIPN, particularly in decreasing neuropathic pain and improving neurotoxicity, the study aims to determine the beneficial effects of acupuncture on CIPN with a large-scale, multicenter, randomized sham-controlled clinical trial. Furthermore, the aim of the study will provide evidence for the clinical therapeutic guideline of CIPN in the future.

Details
Condition Chemotherapy Induced Peripheral Neuropathy
Treatment Acupuncture, Minimal Acupuncture
Clinical Study IdentifierNCT04739631
SponsorTaipei Veterans General Hospital, Taiwan
Last Modified on3 May 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

The study will enroll patients with a symptom of peripheral neuropathy
including paresthesia, numbness, glove-and-stocking sensory loss distribution
or pain in four limbs, and meet the following inclusion criteria
All adult cancer patients (Age20-year-old) who received chemotherapy regimens, including adjuvant and neoadjuvant therapy
Stage I-III cancer patients
Completed chemotherapy regimens more than3 months, including Taxanes (paclitaxel or docetaxel), platinum (cisplatin, oxaliplatin, carboplatin)
Baseline von Frey Monofilament test (Target force at hand) 0.07gms
Baseline von Frey Monofilament test (Target force at foot) 0.4gms
Eastern Cooperative Oncology Group (ECOG) performance status 3
Grading of peripheral sensory neuropathy in National Cancer Institute- common terminology criteria for adverse events,v5.0 (NCI-CTCAE5) 1
Patients were restricted acupuncture treatment for one month before recruitment
Written patient informed consent

Exclusion Criteria

Participants with any of the following conditions will be excluded
Uncontrolled Diabetic Mellitus, HbA1c7% is inappropriate[19]
Diabetic neuropathy diagnosed before receiving chemotherapy
Neuropathy from any type of nerve compression (e.g., carpal/tarsal tunnel syndrome, radiculopathy, spinal stenosis, brachial plexopathy)
Concomitant with duloxetine, or another analgesia, including Pregabalin, Venlafaxine, Minocycline, Topical gel, Oxycodone, Naloxone, Cannabinoids, and Angiotensin II type 2 receptor antagonist
Severe hemorrhagic coagulopathy or bleeding tendency
Unstable cardiovascular disease
Severe skin lesions around the treatment sites The researchers will exclude any participants considered to be inappropriate for the study
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note